Cargando…
Evolution of In Silico Strategies for Protein-Protein Interaction Drug Discovery
The advent of advanced molecular modeling software, big data analytics, and high-speed processing units has led to the exponential evolution of modern drug discovery and better insights into complex biological processes and disease networks. This has progressively steered current research interests...
Autores principales: | Macalino, Stephani Joy Y., Basith, Shaherin, Clavio, Nina Abigail B., Chang, Hyerim, Kang, Soosung, Choi, Sun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6222862/ https://www.ncbi.nlm.nih.gov/pubmed/30082644 http://dx.doi.org/10.3390/molecules23081963 |
Ejemplares similares
-
Exploring G Protein-Coupled Receptors (GPCRs) Ligand Space via Cheminformatics Approaches: Impact on Rational Drug Design
por: Basith, Shaherin, et al.
Publicado: (2018) -
In Silico Strategies in Tuberculosis Drug Discovery
por: Macalino, Stephani Joy Y., et al.
Publicado: (2020) -
Toward antituberculosis drugs: in silico screening of synthetic compounds against Mycobacterium tuberculosis
l,d-transpeptidase 2
por: Billones, Junie B, et al.
Publicado: (2016) -
In silico discovery and in vitro activity of inhibitors against Mycobacterium tuberculosis 7,8-diaminopelargonic acid synthase (Mtb BioA)
por: Billones, Junie B, et al.
Publicado: (2017) -
Structure-Function Relationship of Cytoplasmic and Nuclear IκB Proteins: An In Silico Analysis
por: Manavalan, Balachandran, et al.
Publicado: (2010)